Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
作者信息
Kawamoto Keisuke, Suzuki Takaharu, Kasami Takuya, Kiryu Maiko, Sone Hirohito, Miyoshi Hiroaki, Ohshima Koichi, Takizawa Jun
机构信息
Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
出版信息
Hematol Oncol. 2019 Apr;37(2):212-214. doi: 10.1002/hon.2565. Epub 2018 Nov 19.
DOI:10.1002/hon.2565
PMID:30394560
Abstract
摘要
Zotero 插件